RLMD 10-Q: SEC filing

RELMADA THERAPEUTICS

Filed with the SEC on · accession 0001213900-26-118916

RLMD filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -6.1% by the first close after the filing.

Summary of the filing

RELMADA THERAPEUTICS filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including equity transactions, license agreements, and office lease amendments.

Key details

FilerRELMADA THERAPEUTICS, INC.

How RLMD stock reacted

Close before

$4.43

Nov 11, 2026

First close after

-6.09%

$4.16

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for RLMD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for RLMD?

Click here

Frequently asked questions

What did RLMD file with the SEC on Nov 12, 2026?

RLMD filed a 10-Q (SEC filing). RELMADA THERAPEUTICS filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and disclosures including equity transactions, license agreements, and office lease amendments.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did RLMD stock react to this filing?

RLMD closed at $4.43 before the filing and $4.16 on Nov 12, 2026 (-6.09%).

Other RLMD SEC filings

Get alerts when RLMD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days